ITMI20021392A1 - Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' - Google Patents
Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'Info
- Publication number
- ITMI20021392A1 ITMI20021392A1 IT2002MI001392A ITMI20021392A ITMI20021392A1 IT MI20021392 A1 ITMI20021392 A1 IT MI20021392A1 IT 2002MI001392 A IT2002MI001392 A IT 2002MI001392A IT MI20021392 A ITMI20021392 A IT MI20021392A IT MI20021392 A1 ITMI20021392 A1 IT MI20021392A1
- Authority
- IT
- Italy
- Prior art keywords
- liquid drugs
- ambient temperature
- oral administration
- pharmaceutical forms
- better bioavailability
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Priority Applications (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001392A ITMI20021392A1 (it) | 2002-06-25 | 2002-06-25 | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
| CA002491152A CA2491152A1 (en) | 2002-06-25 | 2003-06-20 | Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| CNB038151812A CN1319518C (zh) | 2002-06-25 | 2003-06-20 | 具有改进的生物利用率的液体药物口服药物剂型 |
| ES03760660T ES2285182T3 (es) | 2002-06-25 | 2003-06-20 | Farmacos liquidos en formas orales solidas que tienen biodisponibilidad mejorada. |
| MXPA04012852A MXPA04012852A (es) | 2002-06-25 | 2003-06-20 | Formas farmaceutica orales de farmacos liquidos que tienen biodisponibilidad mejorada. |
| EP03760660A EP1526839B1 (en) | 2002-06-25 | 2003-06-20 | Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| DE60312523T DE60312523T2 (de) | 2002-06-25 | 2003-06-20 | Orale, pharmazeutische Darreichungsformen von flüssigen Medikamenten mit verbesserter Bioverfügbarkeit |
| AU2003246564A AU2003246564B2 (en) | 2002-06-25 | 2003-06-20 | Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| DK03760660T DK1526839T3 (da) | 2002-06-25 | 2003-06-20 | Orale farmaceutiske former for flydende lægemidler med forbedret biotilgængelighed |
| US10/515,621 US20060171969A1 (en) | 2002-06-25 | 2003-06-20 | Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| NZ537204A NZ537204A (en) | 2002-06-25 | 2003-06-20 | Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| PT03760660T PT1526839E (pt) | 2002-06-25 | 2003-06-20 | Formas farmacêuticas orais de fármacos líquidos com biodisponibilidade melhorada |
| PL374388A PL206599B1 (pl) | 2002-06-25 | 2003-06-20 | Kompozycje farmaceutyczne do podawania doustnego ciekłych leków |
| AT03760660T ATE356612T1 (de) | 2002-06-25 | 2003-06-20 | Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit |
| PCT/EP2003/006496 WO2004000273A1 (en) | 2002-06-25 | 2003-06-20 | Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| SI200330822T SI1526839T1 (sl) | 2002-06-25 | 2003-06-20 | Oralne farmacevtske oblike tekočih zdravil z izboljšano biološko uporabnostjo |
| RU2004138554/15A RU2323003C2 (ru) | 2002-06-25 | 2003-06-20 | Пероральные фармацевтические формы жидких лекарственных средств, имеющих улучшенную биодоступность |
| JP2004514802A JP2005530835A (ja) | 2002-06-25 | 2003-06-20 | 改良された生物学的利用能を有する液体薬剤の経口医薬形態 |
| IL16560103A IL165601A0 (en) | 2002-06-25 | 2003-06-20 | Oral pharmaceutical forms of liquid drugs having improved bioavailability |
| KR1020047021307A KR20060076136A (ko) | 2002-06-25 | 2003-06-20 | 향상된 생체이용율을 가진 액상 약제들의 경구적 조제형태들 |
| ZA200410109A ZA200410109B (en) | 2002-06-25 | 2004-12-14 | Oral pharmaceutical forms of liquid drugs having improved bioavailability. |
| NO20050347A NO20050347L (no) | 2002-06-25 | 2005-01-21 | Flytende legemidler i oral farmasoytisk form med bedret biotilgjengelighet |
| HK06100214.4A HK1080364B (zh) | 2002-06-25 | 2006-01-05 | 具有改進的生物利用率的液體藥物口服藥物劑型 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002MI001392A ITMI20021392A1 (it) | 2002-06-25 | 2002-06-25 | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITMI20021392A0 ITMI20021392A0 (it) | 2002-06-25 |
| ITMI20021392A1 true ITMI20021392A1 (it) | 2003-12-29 |
Family
ID=11450079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT2002MI001392A ITMI20021392A1 (it) | 2002-06-25 | 2002-06-25 | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20060171969A1 (it) |
| EP (1) | EP1526839B1 (it) |
| JP (1) | JP2005530835A (it) |
| KR (1) | KR20060076136A (it) |
| CN (1) | CN1319518C (it) |
| AT (1) | ATE356612T1 (it) |
| AU (1) | AU2003246564B2 (it) |
| CA (1) | CA2491152A1 (it) |
| DE (1) | DE60312523T2 (it) |
| DK (1) | DK1526839T3 (it) |
| ES (1) | ES2285182T3 (it) |
| HK (1) | HK1080364B (it) |
| IL (1) | IL165601A0 (it) |
| IT (1) | ITMI20021392A1 (it) |
| MX (1) | MXPA04012852A (it) |
| NO (1) | NO20050347L (it) |
| NZ (1) | NZ537204A (it) |
| PL (1) | PL206599B1 (it) |
| PT (1) | PT1526839E (it) |
| RU (1) | RU2323003C2 (it) |
| SI (1) | SI1526839T1 (it) |
| WO (1) | WO2004000273A1 (it) |
| ZA (1) | ZA200410109B (it) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
| US20030148818A1 (en) * | 2002-01-18 | 2003-08-07 | Myrhum Mark C. | Golf club woods with wood club head having a selectable center of gravity and a selectable shaft |
| SE0200895D0 (sv) * | 2002-03-22 | 2002-03-22 | Astrazeneca Ab | New pharmaceutical composition |
| AU2003248642A1 (en) | 2002-06-11 | 2003-12-22 | Nitromed, Inc. | Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| CA2491127A1 (en) | 2002-07-03 | 2004-01-15 | Nitromed, Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| DK1803444T3 (en) | 2002-12-20 | 2019-02-25 | Niconovum Ab | PROCEDURE FOR PREPARING A NICOTIC PARTICULATE MATERIAL WITH A CRYSTALLINE CELLULOSE (ESPECIALLY MCC) |
| FR2873923B1 (fr) * | 2004-08-05 | 2007-01-12 | Gattefosse Holding Sa | Particule solide anhydre contenant une composition lipidique liquide et composition pharmaceutique contenant lesdites particules |
| US20090169583A1 (en) * | 2005-02-08 | 2009-07-02 | Pfizer, Inc. | Solid Adsorbates of Hydrophobic Drugs |
| ATE554656T1 (de) * | 2005-03-04 | 2012-05-15 | Dsm Ip Assets Bv | Teilchenförmige nahrungsmittel-lipid- zusammensetzung |
| CA2620299A1 (en) * | 2005-09-16 | 2007-03-22 | Dsm Ip Assets B.V. | Particulate lipid pharmaceutical composition |
| ATE485261T1 (de) | 2005-11-23 | 2010-11-15 | Nicox Sa | Salicylsäurederivate |
| KR20080097989A (ko) * | 2006-02-03 | 2008-11-06 | 니콕스 에스. 에이. | 근위축증 치료를 위한 의약의 니트록시 유도체의 용도 |
| WO2007104573A2 (en) | 2006-03-16 | 2007-09-20 | Niconovum Ab | Improved snuff composition |
| WO2008134013A2 (en) * | 2007-04-25 | 2008-11-06 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical excipient complex |
| WO2009149053A2 (en) * | 2008-06-02 | 2009-12-10 | Dr. Reddy's Laboratories Ltd. | Naproxcinod process and solid dispersion |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| US9044035B2 (en) | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
| KR102237799B1 (ko) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물 |
| CN102964250A (zh) * | 2012-11-19 | 2013-03-13 | 吉林大学 | 氟比洛芬丁香酚酯药用化合物及其制剂和制备方法 |
| CN105188677A (zh) | 2013-03-13 | 2015-12-23 | 特瑞斯制药股份有限公司 | 苯佐那酯调释固体片剂和胶囊剂 |
| US9180104B2 (en) | 2013-03-13 | 2015-11-10 | Tris Pharma, Inc. | Benzonatate modified release solid tablets and capsules |
| US11793230B2 (en) | 2019-12-09 | 2023-10-24 | Nicoventures Trading Limited | Oral products with improved binding of active ingredients |
| US11872231B2 (en) | 2019-12-09 | 2024-01-16 | Nicoventures Trading Limited | Moist oral product comprising an active ingredient |
| MX2022007013A (es) | 2019-12-09 | 2022-09-07 | Nicoventures Trading Ltd | Producto oral que comprende un canabinoide. |
| US11826462B2 (en) | 2019-12-09 | 2023-11-28 | Nicoventures Trading Limited | Oral product with sustained flavor release |
| WO2021116834A1 (en) * | 2019-12-09 | 2021-06-17 | Nicoventures Trading Limited | Nanoemulsion for oral use |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5266615A (en) * | 1975-11-29 | 1977-06-02 | Sawai Seiyaku Kk | Manufacturing of solidified oily liquid substance |
| JPS56169622A (en) * | 1980-06-03 | 1981-12-26 | Kissei Pharmaceut Co Ltd | Method of making solid preparation from oily substance |
| JPS58213073A (ja) * | 1982-06-07 | 1983-12-10 | Masatoshi Yamada | 油状物質の固形化法 |
| US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
| US5968542A (en) * | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
| IL133672A0 (en) * | 1997-06-27 | 2001-04-30 | Vivorx Pharmaceuticals Inc | Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| JP2000016934A (ja) * | 1998-06-30 | 2000-01-18 | Eisai Co Ltd | テプレノンを含有した錠剤 |
| ATE462417T1 (de) * | 1998-08-13 | 2010-04-15 | Cima Labs Inc | Microemulsionen als feste dosisformen zur oralen verabreichung |
| DK1140027T3 (da) * | 1998-12-23 | 2006-02-27 | Alza Corp | Doseringsformer indeholdende poröse partikler |
| US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| US6793934B1 (en) * | 1999-12-08 | 2004-09-21 | Shire Laboratories, Inc. | Solid oral dosage form |
| SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| SE0200895D0 (sv) * | 2002-03-22 | 2002-03-22 | Astrazeneca Ab | New pharmaceutical composition |
-
2002
- 2002-06-25 IT IT2002MI001392A patent/ITMI20021392A1/it unknown
-
2003
- 2003-06-20 PL PL374388A patent/PL206599B1/pl not_active IP Right Cessation
- 2003-06-20 DK DK03760660T patent/DK1526839T3/da active
- 2003-06-20 IL IL16560103A patent/IL165601A0/xx not_active IP Right Cessation
- 2003-06-20 KR KR1020047021307A patent/KR20060076136A/ko not_active Application Discontinuation
- 2003-06-20 PT PT03760660T patent/PT1526839E/pt unknown
- 2003-06-20 DE DE60312523T patent/DE60312523T2/de not_active Expired - Lifetime
- 2003-06-20 RU RU2004138554/15A patent/RU2323003C2/ru not_active IP Right Cessation
- 2003-06-20 WO PCT/EP2003/006496 patent/WO2004000273A1/en active IP Right Grant
- 2003-06-20 US US10/515,621 patent/US20060171969A1/en not_active Abandoned
- 2003-06-20 AU AU2003246564A patent/AU2003246564B2/en not_active Ceased
- 2003-06-20 MX MXPA04012852A patent/MXPA04012852A/es active IP Right Grant
- 2003-06-20 CN CNB038151812A patent/CN1319518C/zh not_active Expired - Fee Related
- 2003-06-20 AT AT03760660T patent/ATE356612T1/de not_active IP Right Cessation
- 2003-06-20 SI SI200330822T patent/SI1526839T1/sl unknown
- 2003-06-20 ES ES03760660T patent/ES2285182T3/es not_active Expired - Lifetime
- 2003-06-20 EP EP03760660A patent/EP1526839B1/en not_active Expired - Lifetime
- 2003-06-20 CA CA002491152A patent/CA2491152A1/en not_active Abandoned
- 2003-06-20 JP JP2004514802A patent/JP2005530835A/ja active Pending
- 2003-06-20 NZ NZ537204A patent/NZ537204A/en not_active IP Right Cessation
-
2004
- 2004-12-14 ZA ZA200410109A patent/ZA200410109B/xx unknown
-
2005
- 2005-01-21 NO NO20050347A patent/NO20050347L/no not_active Application Discontinuation
-
2006
- 2006-01-05 HK HK06100214.4A patent/HK1080364B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2491152A1 (en) | 2003-12-31 |
| SI1526839T1 (sl) | 2007-08-31 |
| DK1526839T3 (da) | 2007-05-21 |
| EP1526839B1 (en) | 2007-03-14 |
| DE60312523D1 (de) | 2007-04-26 |
| US20060171969A1 (en) | 2006-08-03 |
| JP2005530835A (ja) | 2005-10-13 |
| HK1080364A1 (en) | 2006-04-28 |
| KR20060076136A (ko) | 2006-07-04 |
| NO20050347L (no) | 2005-01-21 |
| MXPA04012852A (es) | 2005-06-08 |
| PL374388A1 (en) | 2005-10-17 |
| RU2004138554A (ru) | 2005-08-27 |
| EP1526839A1 (en) | 2005-05-04 |
| IL165601A0 (en) | 2006-01-15 |
| DE60312523T2 (de) | 2008-01-10 |
| ATE356612T1 (de) | 2007-04-15 |
| ES2285182T3 (es) | 2007-11-16 |
| PT1526839E (pt) | 2007-06-06 |
| CN1665486A (zh) | 2005-09-07 |
| AU2003246564B2 (en) | 2008-06-12 |
| CN1319518C (zh) | 2007-06-06 |
| WO2004000273A1 (en) | 2003-12-31 |
| RU2323003C2 (ru) | 2008-04-27 |
| HK1080364B (zh) | 2008-02-01 |
| NZ537204A (en) | 2006-07-28 |
| AU2003246564A1 (en) | 2004-01-06 |
| ZA200410109B (en) | 2005-09-02 |
| ITMI20021392A0 (it) | 2002-06-25 |
| PL206599B1 (pl) | 2010-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI20021392A1 (it) | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' | |
| TR200200561T2 (tr) | Mesalazin içeren ve vücut içinde kontrollü bir şekilde salgılanabilen ağızdan alınan farmasötik bileşimler | |
| ATE293995T1 (de) | Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten | |
| TNSN04023A1 (fr) | Formulation de suspension orale stabilisee | |
| TR200002812T2 (tr) | Efervesan formülasyonları. | |
| ATE307808T1 (de) | Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser | |
| FR2825023B1 (fr) | Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif | |
| DK1183014T3 (da) | Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse | |
| SE0003449D0 (sv) | Anticancer compositions | |
| BRPI0307117B8 (pt) | amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos | |
| DE69808463T2 (de) | Selbstemulgierende formulierung enthaltend saure lipophile verbindungen | |
| ITMI20021726A1 (it) | Macrolidi ad attivita' antiinfiammatoria. | |
| HUP0103781A2 (hu) | Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák | |
| DE50005529D1 (de) | Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac | |
| DK1104289T3 (da) | Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister | |
| DK1401405T3 (da) | Orale, farmaceutiske sammensætninger med forbedret biotilgængelighed | |
| BR9807330A (pt) | Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo | |
| UY27920A1 (es) | Combinaciones de epinastina, pseudoefedrina y metilefedrina como nuevas formulaciones farmaceuticas | |
| FR2843301B1 (fr) | Forme galenique pour la delivrance colique de principes actifs | |
| DK1061938T3 (da) | Orale sammensætninger med cytotoksiske proteiner i lav dosis | |
| FR2839645B1 (fr) | Systeme multilamellaire pour l'administration de substances actives (en particulier des medicaments) par ingestion par la voie orale | |
| BR0202252A (pt) | Composição farmacêutica solúvel estável para administração de inibidores da hiv protease e processo de obtenção de composições farmacêuticas concentradas para a administração de inibidores da hiv protease | |
| DK1275383T3 (da) | "Modified release" farmaceutisk komposition, der indeholder Bupropion HCI som aktivt stof | |
| BR0113055A (pt) | Preparação sólida altamente absorvìvel | |
| EA200101157A1 (ru) | 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ |